Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)‘s stock had its “hold” rating reaffirmed by Stifel Nicolaus in a research note issued to investors on Friday. They presently have a $22.00 target price on the real estate investment trust’s stock. Stifel Nicolaus’ target price would indicate a potential upside of 12.13% from the stock’s previous close.

A number of other analysts have also weighed in on the stock. Zacks Investment Research upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $24.00 target price on the stock in a research note on Tuesday, August 29th. Cantor Fitzgerald restated a “buy” rating and set a $30.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, September 8th. JMP Securities upgraded shares of Sabra Healthcare REIT from a “market perform” rating to an “outperform” rating and set a $23.00 target price on the stock in a research note on Tuesday, September 5th. Bank of America Corporation upped their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research note on Friday, September 8th. Finally, ValuEngine upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the stock. Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $24.90.

Sabra Healthcare REIT (SBRA) traded down $0.30 during mid-day trading on Friday, hitting $19.62. 2,237,657 shares of the company were exchanged, compared to its average volume of 1,392,503. The stock has a market cap of $3,496.92, a PE ratio of 8.61 and a beta of 0.94.

TRADEMARK VIOLATION WARNING: “Sabra Healthcare REIT’s (SBRA) Hold Rating Reaffirmed at Stifel Nicolaus” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/11/03/sabra-healthcare-reits-sbra-hold-rating-reaffirmed-at-stifel-nicolaus.html.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Sabra Healthcare REIT by 6.4% in the second quarter. Vanguard Group Inc. now owns 13,229,559 shares of the real estate investment trust’s stock valued at $318,832,000 after acquiring an additional 797,491 shares during the period. BlackRock Inc. boosted its holdings in shares of Sabra Healthcare REIT by 3.0% in the second quarter. BlackRock Inc. now owns 9,570,432 shares of the real estate investment trust’s stock valued at $230,649,000 after acquiring an additional 277,421 shares during the period. BlackRock Fund Advisors boosted its holdings in shares of Sabra Healthcare REIT by 9.1% in the third quarter. BlackRock Fund Advisors now owns 4,771,441 shares of the real estate investment trust’s stock valued at $120,145,000 after acquiring an additional 397,912 shares during the period. LSV Asset Management boosted its holdings in shares of Sabra Healthcare REIT by 8.7% in the second quarter. LSV Asset Management now owns 3,019,936 shares of the real estate investment trust’s stock valued at $72,780,000 after acquiring an additional 241,022 shares during the period. Finally, APG Asset Management US Inc. boosted its holdings in shares of Sabra Healthcare REIT by 160.6% in the third quarter. APG Asset Management US Inc. now owns 2,874,000 shares of the real estate investment trust’s stock valued at $63,056,000 after acquiring an additional 1,771,033 shares during the period. 99.26% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.